-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
EURBörse Börse Berlin-
EURChemoCentryxBörse Börse Berlin
-
CHEMOCENTRYX INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 2CX
-
CHEMOCENTRYX INCBörse Börse FrankfurtEURSymbol 2CX
-
CHEMOCENTRYX INCBörse Börse DüsseldorfEURSymbol 2CX
-
CHEMOCENTRYX INCBörse Gettex System der Börse MünchenEURSymbol 2CX
-
CHEMOCENTRYX INCBörse Quotrix System der Börse DüsseldorfEURSymbol 2CX
-
ISIN US16383L1061 WKN: A0NBM2USDSymbol CCXI
-
EURSymbol 2CX
-
EUR
-
EUR
-
Firmenname
ChemoCentryx, Inc
Marktkapitalisierung
2.535.696.928 (+- 77%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
4.494.393.856 oder 577.000.000
Mitarbeiter
130 (+- 37%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
82 oder 178 Mitarbeiter
EBITDA -50.917.000
Buchwert 5.858
ChemoCentryx underperformed den DAX um -69 % vom 27.11.2019 bis 29.07.2021
6 ETFs die in ChemoCentryx investieren
Dir gefallen die Informationen zu ChemoCentryx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu ChemoCentryx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu ChemoCentryx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu ChemoCentryx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
34 News & Informationen zur ChemoCentryx Aktie
Emerald Advisers Inc Buys MediaAlpha Inc, Hayward Holdings Inc, MannKind Corp, Sells Installed Building Products Inc, Addus HomeCare Corp, Allegro Microsystems Inc
GuruFocus Article or News written by insider and the topic is about:
First Hawaiian, Inc. (FHB): Are Hedge Funds Right About This Stock?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…
Where Do Hedge Funds Stand On LivaNova PLC (LIVN)?
Is LivaNova PLC (NASDAQ:LIVN) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying…
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, In…
Is Now the Time to Buy ChemoCentryx Stock?
Analysts following this risky biotech stock have changed their tune.
ChemoCentryx (CCXI) Files Amendment to NDA for Avacopan
ChemoCentryx (CCXI) files an amendment to its NDA for avacopan for treatment of ANCA-associated vasculitis. The new PDUFA date is Oct 7. The filing constitutes a major amendment to the original NDA.
Hedge Funds Are Selling LivePerson, Inc. (LPSN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, July 05, 2021 — Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following…
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for ChemoCentryx, Inc. Investors – CCXI
RADNOR, Pa., July 5, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. on… | July 5, 2021
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for ChemoCentryx, Inc. Investors – CCXI
/PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx,…
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder For ChemoCentryx, Inc. Investors – CCXI
RADNOR, Pa., July 5, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Shareholders of Securities Fraud Class Action Lawsuit
RADNOR, Pa., July 04, 2021 — The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. investors that a securities fraud class action lawsuit has been filed in the…
Biotech Losers In 2021 That Could Bounce Big In The Second Half
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary …
CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. on behalf of those who purchased or acquired… | July 3, 2021
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the ye…
CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoC
Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until July 6, 2021 to file lead plaintiff… | July 3, 2021
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, La., July 02, 2021 — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: …
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, La., July 02, 2021 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the…
Is It Too Late to Buy ChemoCentryx Stock?
This biotech is traveling in uncharted waters.
The Law Offices Of Frank R. Cruz Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
The Law Offices of Frank R. Cruz reminds investors of the upcoming July 6, 2021deadline to file a lead plaintiff motion in the case filed on behalf of
CCXI Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors or July 6, 2021 Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., June 29, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. investors that a securities fraud class action lawsuit has been filed… | June 30, 2021
CCXI Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors Or July 6, 2021 Deadline In Securities Fraud Class Action Lawsuit
RADNOR, Pa., June 29, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. CCXI (“ChemoCentryx”) investors that a
FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
CEDARHURST, N.Y., June 29, 2021 — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc….
DEADLINE ALERT for VWAGY, CCIV, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, June 28, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action – CCXI
NEW YORK, June 26, 2021 — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. between November 26, 2019 and May 6, 2021,…
(CCXI) Deadline Alert: Investors With Losses Over $100,000 Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against ChemoCentryx Inc. – Contact Johnson Fistel
SAN DIEGO, June 25, 2021 — Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of ChemoCentryx Inc. . The…
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, June 25, 2021 — Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following…
Cormorant Asset Management, LLC Buys Design Therapeutics Inc, Edgewise Therapeutics Inc, Tarsus Pharmaceuticals Inc, Sells Beam Therapeutics Inc, Immunovant Inc,
GuruFocus Article or News written by insider and the topic is about:
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a…
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, June 23, 2021 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the…
Is ChemoCentryx a Buy?
Next month is sure to be a big one for the company, with the FDA slated to make a decision on its most advanced drug, avacopan.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. – CCXI
NEW YORK, June 22, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ('ChemoCentryx' or the…
ChemoCentryx: Great Drug, Good Prospects, Uncomfortable Stock Price (NASDAQ:CCXI)
Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020
Los Angeles, USA , Jan. 13, 2021 (GLOBE NEWSWIRE) — Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020
NASH Drug Pipeline Shows Promise as …